Evidence map›Paper›PMID 34356742›Full record

ArticleAntibiotics (Basel, Switzerland)2021

The Role of ArlRS and VraSR in Regulating Ceftaroline Hypersusceptibility in Methicillin-Resistant

Maite Villanueva, Melanie Roch, Iñigo Lasa, Adriana Renzoni, William L Kelley

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Proteomic assay for rapid characterisation of Staphylococcus aureus antimicrobial resistance mechanisms directly from blood cultures.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  2. Crosstalk involving two-component systems inJournal of bacteriology · 2024
    Review
  3. TheMicroorganisms · 2024
    Article
  4. Microbiology spectrum · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maite VillanuevaDepartment of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1206 Geneva, Switzerland.ORCID 0000-0002-3894-0060
Melanie RochDepartment of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1206 Geneva, Switzerland.
Iñigo LasaLaboratory of Microbial Pathogenesis, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.
Adriana RenzoniService of Infectious Diseases, University Hospital and Medical School of Geneva, 1206 Geneva, Switzerland.
William L KelleyDepartment of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1206 Geneva, Switzerland.ORCID 0000-0002-0736-4064
University Hospital of Geneva · CHUniversidad Publica de Navarra · ES

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung AR 310030-169404Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung WLK 10030-146540Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung WLK10030-192784
6 · The paper itself

Abstract

Methicillin-resistant

Indexed as

ArlRSceftarolineMRSAStaphylococcus aureustwo-component systemsVraSR

Identifiers

PMID34356742
PMCPMC8300640
OpenAlexW3181138780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.